Biology before scores.
A model score is meaningful only in context. Mechanism, assay conditions, and disease relevance shape how a prediction should be interpreted.
The platform
From biological complexity
to testable ideas.
Our platform vision connects biological context, molecular design, and experimental learning in one continuous discovery process.
Better questions.
More informed decisions.
Drug discovery is a sequence of decisions under uncertainty. We see AI as a way to make those decisions more informed—not to remove the need for scientific judgment.
The approach begins with a disease mechanism, explores potential molecular interventions, and uses evidence to decide what deserves the next experiment.
Explore the discovery cycle
Understand. Design. Learn.
Biological context
Find the question worth asking.
Bring together evidence about targets, pathways, and molecular interactions to define a therapeutic hypothesis. Examine both what the evidence supports and what remains unknown.
Decision: What mechanism should the next experiment investigate?
Design principles
Built around the realities
of discovering medicines.
More than binding.
Useful molecules need more than affinity. Selectivity, exposure, safety, and practical synthesis belong in the same conversation.
Keep the reasoning visible.
Decisions should connect back to evidence, assumptions, and model limitations, so that a new finding can change the course of a program.